RACE-CARS - RAndomized Cluster Evaluation of Cardiac ARrest Systems
Launched by DUKE UNIVERSITY · Dec 3, 2020
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • OHCA of non-traumatic etiology
- • Patients who are pulseless on arrival of a first responder; or patients who become pulseless in the presence of a first responder; OR patients who have a pulse on arrival of EMS, where a successful defibrillation was previously administered by a bystander or first responder.
- Exclusion Criteria:
- * Untreated cardiac arrests, including arrests in which resuscitation efforts are not initiated or are terminated immediately upon arrival of EMS because the patient is not a viable candidate for resuscitation due to:
- • 1. injuries incompatible with life,
- • 2. the presence of rigor mortis or lividity,
- • 3. signs of decomposition, or
- • 4. the presence of a valid DNR.
- • Private EMS transport that did not involve 911 dispatch (example: interfacility transport between nursing home and hospital).
- • Arrest of clear and obvious traumatic etiology
- • Bystander suspected cardiac arrest, where ROSC was achieved without the need for defibrillation or first responder CPR
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Trial Officials
Christopher Granger, MD
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials